The Crookshank lecture: biological response modifiers in the treatment of cancer.
Guillou
P J
PJ
Imperial College of Science, Technology and Medicine, St. Mary's Hospital Medical School, London, U.K.
D000818:Animals; D003131:Combined Modality Therapy; D016207:Cytokines / Q000627:therapeutic use*; D006801:Humans; D007167:Immunotherapy; D015979:Killer Cells, Lymphokine-Activated / Q000276:immunology; D016246:Lymphocytes, Tumor-Infiltrating / Q000276:immunology; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*
D016207:Cytokines